A 17-year-old Caucasian male, smoker (20 cigarettes/day), without no other drug or alcohol consumption, previously vaccinated with two doses of SARS-CoV-2 vaccine and with an unremarkable medical history, presented to the pediatric emergency department with an 11-day history of dyspnea on mild exertion, thoracalgia, and bloody sputum for the previous 4 days. At presentation, examination revealed cutaneous pallor, respiratory distress, hypoxemia (saturation of 87% on room air), and crackles on pulmonary auscultation. Initial laboratory tests ( Table 1) were positive for leukocytosis (14340/μL), neutrophilia (10700/μL), elevated C-reactive protein (148.4 mg/L), and normal kidney function (serum creatinine of 0.74 mg/dL/dL and serum urea of 24 mg/dL). Due to significant respiratory distress, computed tomography angiography (Angio-CT) of the thorax was performed, revealing multiple micronodular opacities, and pulmonary embolism was excluded. Polymerase chain reaction (PCR) testing for SARS-CoV-2 was also performed, and a positive result was obtained. The patient was admitted on supplemental oxygen, but respiratory distress worsened to the point of requiring ventilatory support. He was transferred to the pediatric intensive care unit (PICU) for further care and management. During his stay in the PICU, angio-CT was repeated, demonstrating a consolidation with atelectasis centered in the apical and posterior segments of the lungs (shown in Figure 1). The remaining parenchyma was airy and filled with multiple diffuse, centrilobular, micronodular opacities that only spared the pleural surface and fissures, a pattern that suggested subacute hypersensitivity pneumonitis. He was started on intravenous antibiotics (piperacillin-tazobactam was switched to imipenem and vancomycin due to clinical worsening and an increase in inflammatory markers). Immunological studies were performed and proved negative for the following antibodies: anti-nuclear (ANA), anti-neutrophil cytoplasmatic (ANCA), anti-cardiolipin, anti-extractable nuclear antigen (ENA), and rheumatoid factor. Blood cultures and bacteriological and mycological cultures of respiratory secretions were negative. Interferon Gamma Release Assay (IGRA) was also negative. The patient’s clinical condition deteriorated, and showed to be refractory to mechanical ventilation. He was placed on extracorporeal membrane oxygenation (ECMO) and started on high-dose steroid therapy. Bronchoscopy and bronchoalveolar lavage showed neutrophilia and mild alveolar hemorrhage, and culture exams were negative. Clinically, the patient’s condition improved, steroid doses were progressively decreased, and ECMO was stopped. After ECMO decannulation, cervical doppler was performed, revealing a thrombus filling 20% of the lumen of the right internal jugular vein. Doppler findings of the lower limb veins were normal. Anticoagulation was initiated with apixaban. During this hospitalization, serial blood samples showed slow normalization of the inflammatory markers’ levels. There were no further episodes of hemoptysis and kidney function remained normal, with a maximum serum creatinine level of 0.63 mg/dL, and 0.51 mg/dL at discharge to a rehabilitation unit ( Table 1) due to severe disuse myopathy. During his stay in the rehabilitation unit, the patient remained hemodynamically stable with normal urinary output until 2 months after admission, when he developed fever and gross hematuria. The patient was immediately transferred to the Pediatric Nephrology Unit.